Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: The EAST-AFNET 4 trial

64Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims: A strategy of systematic, early rhythm control (ERC) improves cardiovascular outcomes in patients with atrial fibrillation (AF). It is not known how this outcome-reducing effect is mediated. Methods and results: Using the Early treatment of Atrial Fibrillation for Stroke prevention Trial (EAST-AFNET 4) data set, potential mediators of the effect of ERC were identified in the total study population at 12-month follow up and further interrogated by use of a four-way decomposition of the treatment effect in an exponential model predicting future primary outcome events. Fourteen potential mediators of ERC were identified at the 12-month visit. Of these, sinus rhythm at 12 months explained 81% of the treatment effect of ERC compared with usual care during the remainder of follow up (4.1 years). In patients not in sinus rhythm at 12 months, ERC did not reduce future cardiovascular outcomes (hazard ratio 0.94, 95% confidence interval 0.65-1.67). Inclusion of AF recurrence in the model only explained 31% of the treatment effect, and inclusion of systolic blood pressure at 12 months only 10%. There was no difference in outcomes in patients who underwent AF ablation compared with those who did not undergo AF ablation. Conclusion: The effectiveness of early rhythm control is mediated by the presence of sinus rhythm at 12 months in the EAST-AFNET 4 trial. Clinicians implementing ERC should aim for rapid and sustained restoration of sinus rhythm in patients with recently diagnosed AF and cardiovascular comorbidities.

References Powered by Scopus

The Moderator-Mediator Variable Distinction in Social Psychological Research. Conceptual, Strategic, and Statistical Considerations

62721Citations
N/AReaders
Get full text

Multiple imputation using chained equations: Issues and guidance for practice

6570Citations
N/AReaders
Get full text

A comparison of rate control and rhythm control in patients with atrial fibrillation

3954Citations
N/AReaders
Get full text

Cited by Powered by Scopus

2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

253Citations
N/AReaders
Get full text

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

220Citations
N/AReaders
Get full text

Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials

111Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Eckardt, L., Sehner, S., Suling, A., Borof, K., Breithardt, G., Crijns, H., … Kirchhof, P. (2022). Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: The EAST-AFNET 4 trial. European Heart Journal, 43(40), 4127–4144. https://doi.org/10.1093/eurheartj/ehac471

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 17

53%

Researcher 10

31%

Professor / Associate Prof. 3

9%

Lecturer / Post doc 2

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 25

86%

Nursing and Health Professions 2

7%

Pharmacology, Toxicology and Pharmaceut... 1

3%

Chemistry 1

3%

Article Metrics

Tooltip
Mentions
News Mentions: 12

Save time finding and organizing research with Mendeley

Sign up for free